Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
37m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Catalyst Pharmaceuticals Inc logo

Catalyst Pharmaceuticals Inc

About

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
Mar 6 2026
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
Feb 25 2026
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Feb 24 2026
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
Feb 11 2026
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Financials

Revenue
$588.99 M
Market Cap
$3.03 B
P/E Ratio
14.70
EPS
1.68

Community Chat

Ask AI

6ix6ixAIEvents